Provenienza dei contatti di primo grado di Nicole Bertsch
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
20
| Public Company | Biotechnology | 20 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Nicole Bertsch tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Credit Suisse Securities (USA) LLC (Broker)
 Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Credit Suisse Securities (USA) LLC (Credit Suisse Securities USA) is the broker/dealer division of Credit Suisse Securities (USA) LLC, an investment banking company headquartered in New York City. The firm was founded in 1998 and is a wholly owned subsidiary of Credit Suisse (USA), Inc., ultimately owned by Credit Suisse Group AG (SWX: CSGN) in Switzerland. Credit Suisse Securities USA offers a suite of equities, solutions and credit products and services which includes global securities sales, trading and execution, prime brokerage and comprehensive investment research. Their clients include financial institutions, corporations, governments, institutional investors, such as pension funds and hedge funds, and private individuals around the world. | Investment Banks/Brokers | Analyst-Equity | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Deutsche Bank Securities, Inc.
 Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Deutsche Bank Securities, Inc. (DBSI) is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 1971 and is a wholly-owned investment banking and brokerage arm of DB U.S. Financial Markets Holding Corp., ultimately held by Deutsche Bank AG (NYSE: DB, FRA: DBK) in Germany. DBSI provides securities brokerage and investment advisory services to domestic and international private clients and institutions. They are also a primary dealer in US government securities as designated by the Federal Reserve. | Investment Banks/Brokers | Corporate Officer/Principal | |
| AGENUS INC. | Biotechnology | Investor Relations Contact | |
| James Brudnick Co., Inc. | Chief Executive Officer | ||
Coleman Research Corp.
 Coleman Research Corp. Engineering & ConstructionIndustrial Services Part of L3Harris Technologies, Inc., Coleman Research Corp. is a company that provides aviation and aeronautical engineering. The company is based in Orlando, FL. Coleman Research was acquired by L-3 Communications Holdings, Inc. from Thermo Electron Corp. on January 03, 2001 for $65 million. | Engineering & Construction | Corporate Officer/Principal | |
| THERATECHNOLOGIES INC. | Pharmaceuticals: Major | Director/Board Member | |
ING Financial Markets LLC
 ING Financial Markets LLC Investment Banks/BrokersFinance ING Financial Markets LLC (ING Financial) is a FINRA-registered broker/dealer headquartered in New York City. They have additional offices in Dallas, Houston and Los Angeles. The firm is a wholly-owned subsidiary of ING Financial Holdings Corp, itself a subsidiary of ING Groep NV (AMS: INGA) in The Netherlands. ING Financial offers a broad range of investment services to corporate and financial institutions, as well as other ING businesses. Their research team places a particular emphasis on emerging markets. Key product areas offered are: corporate and government debt, credit and equity derivatives, treasury products (including Repo and CP/CD issuance), interest rate derivatives, foreign exchange, structured products and securities financing. | Investment Banks/Brokers | Analyst-Equity | |
| University of Freiburg | College/University | Doctorate Degree Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree | |
| Yale University | College/University | Doctorate Degree Undergraduate Degree | |
| Tulane University (Louisiana) | College/University | Undergraduate Degree | |
| University of San Francisco | College/University | Masters Business Admin | |
| University of St. Gallen | College/University | Masters Business Admin Graduate Degree | |
| CAMURUS AB | Pharmaceuticals: Major | Director/Board Member | |
| University of Bayreuth | College/University | Undergraduate Degree | |
Affentranger Associates SA
 Affentranger Associates SA Investment ManagersFinance Affentranger Associates SA (aa) is an independent Swiss private equity firm which was founded in 2002 by Anton Affentranger. As principal investor, the firm aims to achieve sustainable long-term returns by combining capital and labor investments in companies in transition. Based in Geneva, aa is strategic advisor to a small group of exclusive clients with whom they seek to build long-term relationships and provide tailored entrepreneurial solutions based on objective advice. | Investment Managers | Private Equity Investor | |
| VIVESTO AB | Pharmaceuticals: Generic | Director/Board Member | |
| Ludwig-Maximilians-Universität München | College/University | Undergraduate Degree | |
| Universität Leipzig | College/University | Undergraduate Degree | |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal | |
| VIVORYON THERAPEUTICS N.V. | Biotechnology | Director of Finance/CFO | |
InflaRx GmbH
 InflaRx GmbH BiotechnologyHealth Technology InflaRx GmbH operates as a biotech company which develops new therapeutics in the field of inflammation. It focuses on the general area of inflammation including indications such as SIRS and SEPSIS by applying innovative therapeutics in order to prevent organ dysfunction or limit progression into organ failure. The firm's complement system is activated and produces large amounts of products including complement 5a (C5a), C3a, C4a and membrane-attack complex (MAC). The company was founded in 2007 by Niels Riedemann and Renfeng Guo and is headquartered in Jena, Germany. | Biotechnology | Chairman Director/Board Member Founder Founder Director/Board Member Director/Board Member | |
European Society for Medical Oncology
 European Society for Medical Oncology Medical/Nursing ServicesHealth Services The European Society for Medical Oncology (ESMO) is a leading medical oncology society that provides a professional network for its members and works with national societies across Europe. The non-profit company is based in Lugano, Switzerland. ESMO's position on a wide range of legislative and non-legislative policy files on both EU and levels is available to learn about. Raffaella Casolino is the third ESMO young medical oncologist serving as a cancer expert on the WHO Cancer Control team. ESMO's Young Oncologists Corner is dedicated to providing educational and networking opportunities for medical oncologists under 40. | Medical/Nursing Services | Corporate Officer/Principal | |
| International Association for the Study of Lung Cancer | Corporate Officer/Principal | ||
Cross Current Research LLC
 Cross Current Research LLC Investment ManagersFinance Founded in 2009 by Dr. Alex To, Cross Current Research LLC is an independent research firm located in Skillman, New Jersey. The firm offers comprehensive fundamental industry and company-specific research, as well as technical analysis of stocks and markets. They cover the healthcare, technology and financial services sectors. Cross Current Research offers services to institutional investors. | Investment Managers | Analyst-Equity | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | President | |
| ADVICENNE | Pharmaceuticals: Generic | Corporate Officer/Principal | |
| VITA 34 AG | Biotechnology | Chief Tech/Sci/R&D Officer | |
| VOLITIONRX LIMITED | Medical Specialties | Director/Board Member | |
| MIT Sloan School of Management | College/University | Masters Business Admin | |
Sanofi AB
 Sanofi AB Medical DistributorsDistribution Services Part of Sanofi, Sanofi AB is a pharmaceutical company based in Stockholm, Sweden. The Swedish company's description states that it is an international pharmaceutical company. | Medical Distributors | Corporate Officer/Principal | |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Investment Managers | Consultant / Advisor | |
| CODIAK BIOSCIENCES | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BIOVERATIV INC | Biotechnology | Corporate Officer/Principal | |
| SCHOLAR ROCK HOLDING CORPORATION | Biotechnology | Director/Board Member | |
Volition America, Inc.
 Volition America, Inc. Medical/Nursing ServicesHealth Services Volition America, Inc. is a company dedicated to advancing the science of epigenetics to revolutionize the diagnosis and monitoring of life-altering diseases. The company is based in Austin, TX. The company's ground-breaking diagnostic solution, ® nets, detects and monitors netosis. The company is committed to improving health outcomes worldwide through earlier disease diagnosis and monitoring. The CEOs of the company are Cameron John Reynolds and Gaetan Michel. | Medical/Nursing Services | Director/Board Member | |
| Oslo Metropolitan University | College/University | Undergraduate Degree | |
| Ullevaal School of Bioengineering | College/University | Undergraduate Degree | |
| IMMATICS N.V. | Biotechnology | Investor Relations Contact | |
| Belnor BVBA | Founder | ||
| OLINK HOLDING AB | Biotechnology | Investor Relations Contact | |
Tamarix Pharma Ltd
 Tamarix Pharma Ltd Pharmaceuticals: MajorHealth Technology Tamarix Pharma Ltd develops a novel small compounds for reducing excessive apoptosis. The company is based in Rehovot, Israel. The CEO of the Israeli company is Isaac Tal. | Pharmaceuticals: Major | Director/Board Member | |
| Jane Goddall Institute Belgium | Director/Board Member | ||
| Royal Free Hospital School of Medicine | College/University | Doctorate Degree | |
| American Association For Cancer Research Foundation | Corporate Officer/Principal |
Statistiche
Distribuzione geografica
| Stati Uniti | 24 |
| Germania | 10 |
| Svezia | 7 |
| Svizzera | 4 |
| Israele | 3 |
Settori
| Health Technology | 20 |
| Consumer Services | 13 |
| Finance | 10 |
| Health Services | 4 |
| Industrial Services | 2 |
Posizioni
| Director/Board Member | 55 |
| Corporate Officer/Principal | 46 |
| Independent Dir/Board Member | 15 |
| Undergraduate Degree | 14 |
| Chairman | 12 |
Contatti più connessi
| Insiders | |
|---|---|
| Nicolas Fulpius | 34 |
| Thomas Taapken | 16 |
| Richard Brudnick | 13 |
| Hege Hellstrom | 11 |
| Jan Medina | 11 |
| Anthony Gibney | 11 |
| Katrin Uschmann | 11 |
| Mark Kubler | 8 |
| Jordan Silverstein | 7 |
| Bruce P. Burnett | 7 |
| Niels Riedemann | 7 |
| Jordan Zwick | 7 |
| Korinna Pilz | 5 |
| Renfeng Guo | 4 |
| Florian Schmid | 3 |
- Borsa valori
- Insiders
- Nicole Bertsch
- Connessioni Società
